Catalyst Wire Dossier Catalyst Wire Dossier

Bicifadine

bicifadine · DOV Pharmaceutical, Inc.
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Bicifadine, covering 2006-06-23 to 2009-06-30. Get the full timeline:

Most recent: Clinical Trial Update: A 52-Week Study of Bicifadine in Patients With Chronic Neuropathic Pain Associated With Diabetic Peripheral Neuropathy [Phase 2]

See pricing